Stocks and Investing Stocks and Investing
Wed, August 2, 2023

Brian Cheng Maintained (BCAB) at Buy with Decreased Target to $17 on, Aug 2nd, 2023


Published on 2024-10-28 05:24:52 - WOPRAI, Brian Cheng
  Print publication without navigation


Brian Cheng of JP Morgan, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $19 to $17 on, Aug 2nd, 2023.

Brian, nor any peers, have made any analyst calls on BCAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources